Structures and luminescence of mononuclear and dinuclear base-stabilized gold(I) pyrazolate complexes

The mono- and dinuclear base-stabilized gold(I) pyrazolate complexes, (PPh₃)Au(μ-3,5-Ph₂pz)) (1), (TPA)Au(3,5-Ph₂pz), TPA=1,3,5-triaza-7-phophaadamantane (2), [(PPh₃)₂Au(μ-3,5-Ph₂pz)]NO₃ (3) and [(dppp)Au(μ-3,5-Ph₂pz)]NO₃, dppp=bis(diphenylphosphino)propane (4), have been synthesized and structurally characterized. The mononuclear gold(I) complexes 1 and 2 show intermolecular Au?Au interactions of 3.1540(6) and 3.092(6) Å, while the dinuclear gold(I) complexes 3 and 4 show an intramolecular Au?Au distances of 3.3519(7) and 3.109(2) Å, respectively, typical of an aurophilic attraction. Complexes 1-4 exhibit luminescence at 77 K when excited with ca. 333 nm UV light with an emission maximum at ca. 454 nm. The emission has been assigned to ligand-to-metal charge transfer, LMCT, based upon the vibronic structure that is observed.     

The synthesis of triethylphosphine gold(I) 4-nitrobenzenethiolate and solvent dependent visible absorption spectra of 4-nitrobenzenethiolate

The synthesis of triethylphosphine gold(I) 4-nitrobenzenethiolate, Et₃PAu(SC₆H₄NO₂-4), is reported. Et₃PAu(SC₆H₄NO₂-4) displays a low energy visible electronic absorption band which is solvent dependent: EtOH (λ_max = 385 nm), acetonitrile (λ_max = 391 nm), THF (λ_max = 395 nm), and DMSO (λ_max = 402 nm). The corresponding low energy visible electronic absorption band of 4-nitrobenzenethiolate, 4-NO₂C₆H₄S⁻ also shows solvent dependency: acetonitrile, (λ_max = 484 nm), DMSO (λ_max = 502 nm), dimethylformamide (λ_max = 505 nm). The positive solvatochromic shifts for Et₃PAu(SC₆H₄NO₂-4) and 4-NO₂C₆H₄S⁻ are consistent with an intraligand (IL) charge transfer transition, i.e. π(S) → ∗π (C₆H₄NO₂-4) or n(S) → ∗π (C₆H₄NO₂-4). Assignment of 4-NO₂C₆H₄S⁻ was aided by a DFT calculation.     

Tuning the Au(I)-mediated inhibition of cathepsin B through ligand substitutions

It has been over 80 years since the antiarthritic properties of gold(I) complexes were first recognized. However, a detailed understanding of their mechanism of action has been slow to develop. One likely biological target of gold(I) is the cathepsin family of lysosomal cysteine proteases, enzymes involved in the inflammation and joint destruction that are hallmarks of rheumatoid arthritis (RA). We have previously shown that analogs of auranofin, a clinically available antiarthritic drug, inhibit cathepsin B. In this study, the extent to which the steric and electronic properties of the phosphine ligand can be modified to obtain enhanced potency against cathepsin B is investigated.     

Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl)dithioacetate ligand

Copper(I) complexes have been synthesized from the reaction of CuCl, monodentate tertiary phosphines PR₃ (PR₃ = P(C₆H₅)₃; P(C₆H₅)₂(4-C₆H₄COOH); P(C₆H₅)₂(2-C₆H₄COOH); PTA, 1,3,5-triaza-7-phosphaadamantane; P(CH₂OH)₃, tris(hydroxymethyl)phosphine) and lithium bis(3,5-dimethylpyrazolyl)dithioacetate, Li[LCS₂]. Mono-nuclear complexes of the type [LCS₂]Cu[PR₃] have been obtained and characterized by elemental analyses, FT-IR, ESI-MS and multinuclear (¹H, ¹³C and ³¹P) NMR spectral data; in these complexes the ligand behaves as a κ³-N,N,S scorpionate system. One exception to this stoichiometry was observed in the complex [LCS₂]Cu[P(CH₂OH)₃]₂, where two phosphine co-ligands are coordinated to the copper(I) centre. The solid-state X-ray crystal structure of [LCS₂]Cu[P(C₆H₅)₃] has been determined. The [LCS₂]Cu[P(C₆H₅)₃] complex has a pseudo tetrahedral copper site where the bis(3,5-dimethylpyrazolyl)dithioacetate ligand acts as a κ³-N,N,S donor.     

Proton-linked bi- and tri-metallic gold cyanide complexes observed by ESI-MS spectrometry

Electrospray ionization spectra of potential cyanide-containing gold-drug metabolites revealed additional, weak, unanticipated peaks at approximately twice the mass of the gold(I) and gold(III) cyanide complexes. The exact masses correspond to proton-linked bimetallic complexes, [H[Au(CN)(m)](2)](-), (m=2,4). Further investigation revealed a total of 12 examples, including trimetallic complexes, [H(2)[Au(CN)(m)](3)](-); mixed species with two complexes, [H[Au(CN)(2)][Au(CN)(4)]](-); and thiolato species, [H[(RS)Au(CN)(3)](2)](-). trans-[AuX(2)(CN)(2)Cl(2)](-) and trans-[AuX(2)(CN)(2)Br(2)](-) generated (35)Cl/(37)Cl and (79)Br/(81)Br isotopic patterns for the protonated bi- and tri-metallic analogues which were in good agreement with the presence of four or six halide ligands, respectively. Concentration-dependent studies demonstrated that the signals are independent of the solution concentrations of mono-metallic precursors, suggesting formation in the gas phase during or following droplet desolvation.     

Synthesis and structural characterization of two new polynuclear metal thiosaccharinates: Hexakis(thiosaccharinato)hexasilver(I) and tetrakis(thiosaccharinato)tetracopper(I)

The title compounds, for short Ag₆(tsac)₆ (1) and [Cu₄(tsac)₄(MeCN)₂] · 2MeCN (2), were prepared by the reaction of thiosaccharin with Ag(I) or Cu(II) salts in different solvents. The new complexes were characterized by FT-IR, Raman, UV-Vis and NMR spectroscopy. Their crystal and molecular structures were determined by X-ray diffraction methods. The structures were solved from 1621 (1) and 7080 (2) reflections with I > 2σ(I) and refined to agreement R1-factors of 0.0261 (1) and 0.0456 (2). Ag₆(tsac)₆ molecule derives from the clustering of six Ag(tsac) moieties related to each other through the crystallographic 3-bar (S₆) symmetry operations of the space group. This results in a highly regular molecular structure where the silver atoms are at the corners of an octahedral core slightly compressed along one of its three-fold axis [inter-metallic Ag?Ag contacts of 3.1723(4) and 3.1556(4) Å]. The six thiosaccharinate ligands bridge neighboring Ag atoms along the C₃-axis through Ag-N bonds [d(Ag-N) = 2.285(2) Å] at one end and bifurcated Ag-S(thione)-Ag bonds [Ag-S distances of 2.4861(7) and 2.5014(8) Å] at the other end. In contrast, the 2 compound is arranged in the lattice as an irregular tetrameric copper complex [Cu₄(tsac)₄(MeCN)₂] where the metals show different environments. Two copper ions are four-fold coordinated to three tsac ions through the N-atom of one tsac [Cu-N distances of 2.112(3) and 2.064(3) Å] and the thione sulfur atom of the other two [Cu-S distances in the range from 2.284(1) to 2.358(1) Å] and to a MeCN solvent molecule [Cu-N distances of 1.983(4) and 2.052(3) Å]. The other two copper ions are in three-fold environment, one trans-coordinated to two tsac ions [Cu-N distances of 1.912(3) and 1.920(3) Å] and to the thione S-atom of a third ligand [d(Cu-S) = 2.531(1) Å], the other one to the thione sulfur atom of three tsac ligands [Cu-S distances in the range from 2.229(1) to 2.334(1) Å]. The clustering renders the metals to short distances from each other, the shorter Cu?Cu distance being 2.6033(7) Å, as to presume the existence of weak inter-metallic interaction within the cluster.     

In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands

Hydrophilic, monocationic [M(L)₄]PF₆ complexes (M = Cu or Ag; L: thp = tris(hydroxymethyl)phosphine, L: PTA = 1,3,5-triaza-7-phosphaadamantane, L: thpp = tris(hydroxypropyl)phosphine) were synthesized by ligand exchange reaction starting from [Cu(CH₃CN)₄]PF₆ or AgPF₆ precursors at room temperature in the presence of an excess of the relevant phosphine. The related [Au(L)₄]PF₆ complexes (L = thp, PTA or thpp) were synthesized by metathesis reactions starting from [Au(L)₄]Cl at room temperature in the presence of equimolar quantity of TlPF₆. The three series of complexes [M(L)₄]PF₆ were tested as cytotoxic agents against a panel of several human tumour cell lines also including a defined cisplatin resistant cell line. These investigations have been carried out in comparison with the clinically used metallodrug cisplatin and preliminary structure-activity relationships are presented. The best results in terms of in vitro antitumour activity were achieved with metal-thp species and, among the coinage metal complexes, copper derivatives were found to be the most efficient drugs. Preliminary studies concerning the mechanism of action of these [M(L)₄]PF₆ species pointed to thioredoxin reductase as one of the putative cellular targets of gold and silver complexes and provided evidence that copper derivatives mediated their cytotoxic effect through proteasome inhibition.     

Synthesis and in vitro evaluation of gold(I) thiosemicarbazone complexes for antimalarial activity

The reaction of thiosemicarbazones (TSCs) with [Au^I(THT)Cl], THT = tetrahydrothiophene, has been investigated. The resulting gold(I) complexes have been characterized by a range of spectroscopic techniques: NMR spectroscopy, mass spectrometry, microanalysis and infrared spectroscopy. The in vitro antimalarial data for gold(I) TSC complexes suggests that coordination of gold(I) to TSCs enhanced their efficacy against the malaria parasite Plasmodium falciparum and their inhibition of the parasite cysteine protease falcipain-2.     

Homoleptic copper(II) and copper(I) complexes of 5,6-dihydro-5,6-epoxy-1,10-phenanthroline. Six-coordinate copper(I) in solution

Reaction of 5,6-dihydro-5,6-epoxy-1,10-phenanthroline (L) with Cu(ClO₄)₂·6H₂O in methanol in 3:1 M ratio at room temperature yields light green [CuL₃](ClO₄)₂·H₂O (1). The X-ray crystal structure of the hemi acetonitrile solvate [CuL₃](ClO₄)₂·0.5CH₃CN has been determined which shows Jahn-Teller distortion in the CuN₆ core present in the cation [CuL₃]²⁺. Complex 1 gives an axial EPR spectrum in acetonitrile-toluene glass with g_|| = 2.262 (A_|| = 169 × 10⁻⁴ cm⁻¹) and g_⊥ = 2.069. The Cu(II/I) potential in 1 in CH₂Cl₂ at a glassy carbon electrode is 0.32 V versus NHE. This potential does not change with the addition of extra L in the medium implicating generation of a six-coordinate copper(I) species [CuL₃]⁺ in solution. B3LYP/LanL2DZ calculations show that the six Cu-N bond distances in [CuL₃]⁺ are 2.33, 2.25, 2.32, 2.25, 2.28 and 2.25 Å while the ideal Cu(I)-N bond length in a symmetric Cu(I)N₆ moiety is estimated as 2.25 Å. Reaction of L with Cu(CH₃CN)₄ClO₄ in dehydrated methanol at room temperature even in 4:1 M proportion yields [CuL₂]ClO₄ (2). Its ¹H NMR spectrum indicates that the metal in [CuL₂]⁺ is tetrahedral. The Cu(II/I) potential in 2 is found to be 0.68 V versus NHE in CH₂Cl₂ at a glassy carbon electrode. In presence of excess L, 2 yields the cyclic voltammogram of 1. From ¹H NMR titration, the free energy of binding of L to [CuL₂]⁺ to produce [CuL₃]⁺ in CD₂Cl₂ at 298 K is estimated as −11.7 (±0.2) kJ mol⁻¹.     

Construction of two novel tungsten(VI)-silver(I) mixed metal clusters controlled by bis(diphenylphosphino) methane and coordinated inorganic anions

By the reaction of [Ag₃(dppm)₃I₂]I with (NH₄)₂WS₄ in MeCN/DMF (1:1), a trigonal bipyramid-shaped cluster [Ag₃ I (dppm)₂ WS₄] (1) was isolated [dppm = bis (diphenylphosphino) methane]. By the reaction of (NH₄)₂WS₄ with AgSCN and dppm in MeCN/DMF (1:1) in the presence of 1,10-phenathroline, an insect-shaped cluster [Ag₄ (SCN)₂ (dppm)₄WS₄]·H₂O (2) was synthesized. Compounds 1 and 2 were characterized by single-crystal X-ray diffraction, luminescence, IR, UV-Vis, ¹H and ³¹P NMR spectroscopy. In 1, and μ₃-I are coordinated to three Ag atoms, which are further bridged by two dppm ligands. In 2, Ag1 and Ag4 are coordinated by two P atoms from two dppm ligands, one μ₃-S from and one S atom from SCN⁻ while Ag2 and Ag3 are coordinated by one μ₂-S atom and one μ₃-S atom from , two P atoms from two dppm ligands.     

Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes

Gold(III) compounds have been recognized as anticancer agents due to their structural and electronic similarities with currently employed platinum(II) species. An added benefit to gold(III) agents is the ability to overcome cisplatin resistance. This work identified four gold(III) compounds, [Au(Phen)Cl₂]PF₆, [Au(DPQ)Cl₂]PF₆, [Au(DPPZ)Cl₂]PF₆, and [Au(DPQC)Cl₂]PF₆, (Phen = 1,10-phenanthroline, DPQ = dipyrido[3,2-d:2′,3′-f]quinoxaline, DPPZ = dipyrido[3,2-a:2′,3′-c] phenazine, DPQC = dipyrido[3,2-d:2′,3′-f] cyclohexyl quinoxaline) that exhibited anticancer activity in both cisplatin sensitive and cisplatin resistant ovarian cancer cells. Two of these compounds, [Au(DPQ)Cl₂]PF₆ (AQ) and [Au(DPPZ)Cl₂]PF₆ (AZ), displayed exceptional anticancer activity and were the focus of more intensive mechanistic study. At the molecular level, AQ and AZ formed DNA adducts, generated free radicals, and upregulated pro-apoptotic signaling molecules (p53, caspases, PARP, death effectors). Taken together, these two novel gold(III) polypyridyl complexes exhibit potent antitumor activity in cisplatin resistant cancer cells. These activities may be mediated, in part, by the activation of apoptotic signaling.     

Two new mononuclear gold(I)-nitrogen [N,N′-di(2,6-methyl)phenylformamidine] complexes: Syntheses and crystal structures

Two gold(I) mononuclear complexes have been prepared by reacting gold(I) tetrahydrothiophene with N,N′-di(2,6-methyl)phenylformamidine. The neutral complex [N,N′-di(2,6-methyl)phenylformamidine)-gold(I) chloride (C₁₇H₂₀AuClN₂) (1), crystallizes in the triclinic group while the cationic [N,N′-di(2,6-methyl)phenylformamidine](tetrahydrothiophene)-gold(I) (C₂₁H₂₈AuN₂S) (2) crystallizes with a nitrate anion in the monoclinic group P2(1)/n. Both compounds are good starting materials for synthetic gold chemistry.     

Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides

Four mixed ligand gold(I) complexes with the thioamides 2-mercapto-thiazolidine (mtzdH), 2-mercapto-benzothiazole (mbztH) and 5-chloro-2-mercapto-benzothiazole (ClmbztH) and triphenylphosphine (tpp) of formulae [Au(tpp)Cl] (1) [Au(tpp)(mtzd)] (2), [Au(tpp)(mbzt)] (3) and [Au(tpp)(Clmbzt)] (4), already known, were used to study their mechanism of inhibition activity towards the catalytic oxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase (LOX), kinetically and theoretically. The results are compared to those of cisplatin. In addition, the anticancer cell screening results against leimyosarcoma (LMS) cells have shown that 2-4 complexes were more active than cisplatin. The uptake of complexes in LMS cells were also studied with electrospray ionisation mass spectrometry spectroscopy.     

Synthesis of a new tetradentate bis(imino-phosphine) ligand and its complexation with copper(I) ions

Schiff base condensation of m-phenylenediamine with two equivalents of o-(diphenylphophino)benzaldehyde products the potentially tetradentate molecule 1,3-(Ph₂P(o-C₆H₄)CHN)₂C₆H₄ (1) in high yield. The reaction of 1 and [Cu(NCMe)₄]BF₄ affords the dinuclear complex [(1,3-(Ph₂P(o-C₆H₄)CHN)₂C₆H₄)₂Cu₂](BF₄)₂ (2) through coordination of the imino-phosphine groups. The structure of 2 has been determined by an X-ray diffraction study.     

In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake

In this study we characterised the in vitro antitumour and hepatotoxicity profiles of a series of Au(I) and Ag(I) bidentate phenyl and pyridyl complexes in a panel of cisplatin-resistant human ovarian cancer cell-lines, and in isolated rat hepatocytes. The gold and silver compounds overcame cisplatin-resistance in the CH1-cisR, 41M-cisR and SKOV-3 cell-lines, and showed cytotoxic potencies strongly correlated with their lipophilicity. Complexes with phenyl or 2-pyridyl ligands had high antitumour and hepatotoxic potency and low selectivity between different cell-lines. Their cytotoxicity profiles were similar to classic mitochondrial poisons and an example of this type of compound was shown to accumulate preferentially in the mitochondria of cancer cells in a manner that depended upon the mitochondrial membrane potential. In contrast, complexes with 3- or 4-pyridyl ligands had low antitumour and hepatotoxic potency and cytotoxicity profiles similar to 2-deoxy-D-glucose. In addition, they showed high selectivity between different cell-lines that was not attributable to variation in uptake in different cell-types. The in vitro hepatotoxic potency of the series of gold and silver compounds varied by over 61-fold and was closely related to their lipophilicity and hepatocyte uptake. In conclusion, Au(I) and Ag(I) bidendate pyridyl phosphine complexes demonstrate activity against cisplatin-resistant human cancer cells and in vitro cytotoxicity that strongly depends upon their lipophilicity.     

The reaction mechanism of nitrosothiols with copper(I)

Copper and other transition metal ions and their complexes are catalysts for the decomposition of nitrosothiols. In this way they catalyze the biological functions of nitrosothiols. The kinetics and mechanism of the reaction of two nitrosothiols, S-nitrosothiolactic acid and S-nitrosoglutathione (GSNO), with copper(I) are reported. The kinetics of the reaction of Cu(MeCN) _n ⁺ (n=0–3) with the nitrosothiols were studied. The results indicate that Cu⁺ _aq is the active species in the GSNO system, with k(Cu⁺ _aq+GSNO)=(9.4 ±2.0)×10⁷ dm³ mol⁻¹ s⁻¹. The results also indicate that the Cu(MeCN) _n ⁺ (n=0–3) complexes react with S-nitrosothiolactic acid. Transient species are formed in these processes. The results suggest that these species contain copper(I) and thiol. The results shed light on the catalytic role of copper complexes in the decomposition of S-nitrosothiols. Received 10 April 1999 / Accepted 17 December 1999     

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

A series of new gold(I) and gold(III) complexes based on the saccharinate (sac) ligand, namely M[Au(sac)₂] (with M being Na⁺, K⁺ or NH₄⁺), [(PTA)Au(sac)], K[Au(sac)₃Cl] and Na[Au(sac)₄], were synthesized and characterized, and some aspects of their biological profile investigated. Spectrophotometric analysis revealed that these gold compounds, upon dissolution in aqueous media, at physiological pH, manifest a rather favourable balance between stability and reactivity. Their reactions with the model proteins cytochrome c and lysozyme were monitored by mass spectrometry to predict their likely interactions with protein targets. In the case of disaccharinato gold(I) complexes, cytochrome c adducts bearing four coordinated gold(I) ions were preferentially formed in high yield. In contrast, [(PTA)Au(sac)] (PTA = 1,3,5-triaza-7-phosphaadamantane) turned out to be poorly effective, only producing a mono-metalated adduct in very low amount. In turn, the gold(III) saccharinate derivatives were less reactive than their gold(I) analogues: K[Au(sac)₃Cl] and Na[Au(sac)₄] caused moderate protein metalation, again with evidence of formation of tetragold adducts. Finally, the above mentioned gold compounds were challenged against the reference human tumor cell line A2780S and its cisplatin resistant subline A2780R and their respective cytotoxic profiles determined. [(PTA)Au(sac)] turned out to be highly cytotoxic whereas moderate cytotoxicities were observed for the gold(III) complexes and only modest activities for disaccharinato gold(I) complexes. The implications of these results are thoroughly discussed in the light of current knowledge on gold based drugs.     

Macrocyclic dinuclear gold(I) and silver(I) NHCs complexes

The ligands bis-(imidazolium) hexafluorophosphate (Himy = -C₃N₂H₃-, imidazolium; R = 1-naphthylmethylene, 1a; 9-anthracenylmethylene, 1b) with an oxoether chain were easily prepared by the reaction of substituted imidazole with the diglycol diiodide, followed by exchange of anions with . 1a and 1b reacted with Ag₂O in DMSO or CH₃CN to yield [2 + 2] dinuclear Ag(I) NHCs macrocyclic complexes 2a and 2b, which showed much different conformation in solid corresponding to the R- substituent. Carbene transmetalation reactions of 2a-b with Au(SMe₂)Cl give dinuclear Au(I) analogs 3a and 3b. The new NHCs complexes were characterized by elemental analyses, ¹H NMR, ¹³C NMR and the structures of 2a-b and 3a were confirmed by X-ray diffraction determination.     

Investigation of the solution behavior of tri-n-butylphosphine copper(I) and silver(I) acetates using P{H} NMR spectroscopy

³¹P{¹H} NMR spectra of metal-organic [(ⁿBu₃P)_mMO₂CMe] (M = Cu, Ag; m = 1, 1.5, 2, 2.5, 3, 3.5, 4) have been studied in the temperature range of 308-178 K. Exchange parameters were determined for the appropriate silver(I) complexes. Possible ligand exchange mechanisms based on dissociative and associative processes are discussed.     

Crystal structure of bis(N-methylethylenediammonium) hexabromodicuprate(I)

The crystal structure of the title compound (C₃H₁₂N₂)₂Cu₂Br₆, is monoclinic, space group P2₁/n, with lattice constants a=8.222(2), b=11.214(2), c=10.646(2) Å, β=91.97(1)° and V=981.0(3) ų. The structure contains anionic Cu₂Br₆²⁻ dimers and N-methylethylenediammonium (henceforth MEDA²⁺) cations. The centrosymmetric dimer units are composed of two edge-shared CuBr₄ tetrahedra, with bridging Cu-Br distances 0.08 Å longer than the terminal distances. A pair of MEDA²⁺ cations hydrogen bond to each dimer via two of the -NH₃⁺ hydrogen atoms and one of the -NH₂⁺- hydrogen atoms. Additional hydrogen bonding between the cations and anions tie the structure together in a complex supramolecular network.